Founded in 2018, Redcliffe Labs operates in Health Tech industry. Initially focused on offering home collection for blood tests and other diagnostics, the company has expanded its services to include ...
Funding stage:
Series C
Last funding:
17/09/2024
Total funding:
$115.00 Mn+
Revenue:
Investors
Employee count:
1,985
Last 90d
1,985
Last 90d
Web traffic:
1.97 Mn
1.97 Mn
Last 30d
Last 30d
Glassdoor Rating:
Redcliffe Labs: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders12
Latest Filing Date26 Sept 2024- Funding Events28
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Redcliffe Labs
As of 27 September 2024, Redcliffe Labs's equity is held by 12 shareholders, with the top three being Redcliffe Labs, The Investment Fund For Developing Countries IFU, and Alkemi Venture Fund I.
Redcliffe Labs holds the largest stake in Redcliffe Labs at 72.5% as of 27 September 2024.
As of 27 September 2024, investors collectively hold 26.2% equity in Redcliffe Labs.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links